Critically ill pediatric patients with persistently low stimulated TNF-α production are more likely to acquire life-threatening infections, and treatment caused rapid improvement in stimulated TNF-α production, which was associated with the prevention of nosocomial infections [15, 16]. The gene discussed is TNF; the disease is nosocomial infection.